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A Review of the Physiological and Immunological Functions of
Biliary Epithelial Cells: Targets for Primary Biliary Cirrhosis,
Primary Sclerosing Cholangitis and Drug-induced Ductopenias
CHIH-TE WUa,*, PAUL A. DAVISa,*,†, VELIMIR A. LUKETICb and M. ERIC GERSHWINa
a

Division of Rheumatology, Allergy and Clinical Immunology, University of California, Davis School of Medicine, Davis, CA 95616, USA; bDivision of
Hepatology, Medical College of Virginia, Richmond, VA 23298, USA

Our understanding of biliary epithelial cells (BEC) in physiobiology and immunology has steadily
expanded. BEC transports IgA as well as IgM into bile, synthesizes and secretes various chemokines,
cytokines, and expresses adhesion molecules involved in cell interaction and signal transduction. These
then suggest a myriad of potential roles for BEC in defense from invading microorganisms as well as
the pathogenesis of diverse immunologically driven diseases such as primary biliary cirrhosis (PBC),
graft-versus-host disease, and primary sclerosing cholangitis (PSC). Despite the progress, there still
remain many areas of BEC biology that require further investigation. Most importantly, it remains to be
clarified that the extent to which the immunologic activities observed in BEC represent a BEC response
to tissue injury or whether BEC themselves are the active participants in the pathogenesis of various
cholestatic immunological diseases, including PBC and PSC.
Keywords: Biliary epithelial cells; Primary biliary cirrhosis; Primary sclerosing cholangitis; IgA

INTRODUCTION
The liver is composed of multiple cell types including two
types of epithelia: hepatocytes, the major epithelial cells and
intrahepatic biliary epithelial cells (BEC), which constitute
3–5% of the nuclear population of the liver (Tavoloni, 1987).
BEC are typical epithelia, forming an extensive interconnecting network of intrahepatic and extrahepatic conduits
which are heterogeneous with regard to diameter as well as
their function. In humans, intrahepatic bile ducts range in size
from 800 mm hepatic ducts to ,15 mm bile ductules.
Physiologically, BEC participate in a variety of fundamental
processes including formation of bile as well as the transport
of IgA into bile. In recent years, it has become apparent that
BEC represent critical targets for a diverse group of diseases,
including primary biliary cirrhosis (PBC), primary
sclerosing cholangitis (PSC) as well as drug-induced ductopenias. In this review, we will focus on the physiological
as well as immunological functions of the BEC.
BILE FORMATION AND ELECTROLYTE
TRANSPORT
Bile formation requires both hepatocytes and BEC as
primary bile is extensively modified by BEC after its

secretion by hepatocytes and prior to its delivery to the
duodenum. BEC are responsible for approximately 30%
of bile volume, a percentage that can be promptly
increased to meet the changing physiological demands
(Nathanson and Boyer, 1991). BEC secrete fluid,
bicarbonate, chloride and immunoglobulin (Ig)A or
reabsorb glucose, bile acids, amino acids, and electrolytes
(Strazzabosco, 1997). The electrolyte transport function of
the BEC is finely regulated by a complex system of
intestinal hormones, neuropeptides, and neurotransmitters
that promote either secretion or absorption. For example,
secretin, which will be discussed in detail later, can
increase the hydration and alkalinity of bile by stimulation
of BEC secretion of chloride and bicarbonate.

BEC SECRETORY PROCESSES
Secretion into the bile is clearly a major function of BEC
as they are a major determinant of alkalinity and hydration
of bile and contribute significantly to the local bicarbonate
needed for digestion. BEC bicarbonate secretion is driven
by the apically located Cl2 =HCO2
3 exchanger, which is
functionally coupled with the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), a cyclic AMP
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(cAMP)-dependent Cl2 channel. As noted earlier, secretin
plays a major role in bicarbonate secretion as upon
binding to its receptor, it increases intracellular cAMP
levels, probably through a Gi-protein mediated induction
of adenylate cyclase (Alvaro et al., 1997a). Once the
intracellular cAMP increases, cAMP-dependent protein
kinase A (PKA) is activated and phosphorylates thereby
activating the regulatory domain of CFTR, a critical step
before the stimulation of bicarbonate secretion (Alvaro
et al., 1993; 1997b). This produces an open Cl2
conductance (Frizzel and Morris, 1994) and results in
BEC mediated secretion of Cl2 into the bile. The BEC
driven rise in bile Cl2 increases the Cl2 =HCO2
3
exchanger activity, leading to increased HCO2
3 secretion
into the bile (in exchange of Cl2 absorption into the BEC).
Interestingly, the apical Cl2 =HCO2
3 exchanger lacks the
ability to be stimulated by cAMP and therefore association
with CFTR is required for cAMP-dependent HCO2
3
secretion. This Cl2 =HCO2
3 exchanger has been localized
to the canalicular membrane of hepatocytes as well as the
apical membrane of small and medium-sized bile ducts
(Martinez-Anso et al., 1994) using monoclonal antibodies
and to the medium and large bile ducts along with the
secretin receptor and CFTR (Alpini et al., 1996) using
functional studies.
Ductal bicarbonate secretion is also stimulated by
bombesin and vasoactive intestinal peptide (VIP). Both of
them, like secretin, enhance the activity of the Cl2 =HCO2
3
exchanger after CFTR activation (Cho et al., 1997a,b).
Conversely, ductal bicarbonate secretion is inhibited by
somatostatin and gastrin. Somatostatin, after binding to
SSTR2 subtype receptors, which are detected almost
exclusively on large bile ducts, inhibits basal and secretinstimulated ductal bile flow. Somatostatin can also inhibit
the secretin-induced increase of intracellular cAMP levels
via a Gi-protein mediated inhibition of adenylate cyclase
activity (Tietz et al., 1995). Gastrin also inhibits secretininduced bicarbonate secretion by decreasing the secretininduced cAMP levels and the expression of secretin
receptor in BEC (Glaser et al., 1997). In contrast to
somatostatin, gastrin does not affect basal bile flow.
Neural pathways also modulate HCO2
3 secretion as
vagal (cholinergic) stimulation increases HCO2
3 secretion
after acetylcholine binding to M3 muscarinic receptors on
the basolateral membrane of BEC. M3 receptor activation
increases intracellular Ca2þ which recruits calcineurin, a
Ca2þ- and calmodulin-dependent serine/threonine protein
phosphatase 2B, that in turn sensitizes specific adenylate
cyclase isoforms to secretin and thereby doubles
intracellular cAMP. This finally results in an almost
maximal stimulation of the Cl2 =HCO2
3 exchanger (Alvaro
et al., 1997c; Alvaro, 1999). This effect is blocked by
M3 muscarinic receptor antagonists, intracellular Ca2þ
chelators, as well as the calcineurin inhibitors, FK-506 and
cyclosporin A (Alvaro et al., 1997c). The secretory
processes of BEC are also regulated by ATP. ATP
increases intracellular Ca2þ, induces intracellular alkalinization (activation of Naþ/Hþ exchanger) and, as

a consequence, enhances the activity of the Cl2 =HCO2
3
exchanger (Elsing et al., 1996; Fitz, 1997; Strazzabosco,
1997). The coordinated regulation of bicarbonate secretion
by secretin (cAMP) and acetylcholine (Ca2þ) could serve
as a means of amplifying the secretory response just when
the bicarbonate requirement in the intestine is maximal,
i.e. the parasympathetic predominant digestive phase.
A number of different ion channels and carriers, in
addition to the Cl2 =HCO2
3 exchanger and CFTR, have also
been identified on BEC. On the basolateral membrane,
there are the Naþ/Hþ exchanger isoform 1 (NHE1), the
þ
þ
Naþ-dependent Cl2 =HCO2
3 exchanger, the Na –K –
þ
þ
2
ATPase, and the Na /K /2Cl cotransporter. The Naþ2
dependent Cl2 =HCO2
3 exchanger absorbs HCO3 into the
þ
þ
cell (Strazzabosco et al., 1997). The Na – K –ATPase
maintains the Naþ gradient and, together with Kþ channels,
determines the membrane potential difference of BEC. The
Naþ/Kþ/2Cl2 cotransporter actively absorbs Cl2 ions into
the cell and appears to be a major determinant of fluid
secretion (Singh et al., 1996). On the luminal surface of
BEC, a Caþ þ -activated Cl2 channel is present which may
be activated by luminal purinergic nucleotides (Strazzabosco et al., 2000). More recent work has demonstrated the
expression of the apical isoforms of Naþ/Hþ exchanger
(NHE2) (Spirli et al., 1998), which enhance Naþ
reabsorption. Figure 1 summarizes the different electrolyte
transport mechanisms in BEC.

FIGURE 1 Mechanisms of electrolyte transport in biliary epithelial
cells. At the apical membrane, the cystic fibrosis transmembrane
conductance regulator (CFTR) (1) is couplewith the Cl2 =HCO2
3
2
exchanger (2), which secretes HCO2
3 in exchange of Cl absorption.
2þ
2
þ
There is another Ca -dependent Cl channel (3) as well as the Na /Hþ
exchanger isoform 2 (NHE2) (4). On the basolateral side of the BEC,
there is Naþ/Hþ exchanger isoform 1 (NHE1) (5) and Kþ channel (6).
þ þ
2
Another type of Cl2 =HCO2
3 exchanger (7) and a Na /K /2Cl
exchanger are also present.
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ABSORPTIVE FUNCTIONS
BEC are also capable of active reabsorption of glucose,
bile acids, glutamate, conjugated bilirubin, sulfobromophthalein, and low molecular weight organic anions which
further modify the final constituents of bile.
In isolated perfused rat livers, BEC absorbs both
metabolizable hexose (D -glucose) and pentose (D -xylose)
as well as nonmetabilizable hexoses (a-methylglucoside, 3-o-methylglucose, and L -glucose) (Lira et al.,
1992). Because in sodium-free media, absorption of
L -glucose and a-methylglucoside gradually ceased while
absorption of D -glucose and 3-o-methylglucose remained
unchanged, there are at least two different sugar transport
systems present.
Active transport processes for conjugated bile acids
have recently been described using isolated rat cholangiocytes (Lazaridis et al., 1997). Conjugated bile acids
were absorbed in a Naþ-dependent fashion at the luminal
BEC surface. Furthermore, immunohistochemistry also
demonstrated the apical localization of the rat ileal Naþdependent bile acid transporter (ASBT). The meaning of
the reabsorption remains to be clarified. However,
intracellular bile acids are capable of modulating many
important intracellular events including the level of
secondary messengers (Ca2þ, cAMP), vesicle trafficking,
ion transport, growth and replication (Alvaro, 1999).
Unlike conjugated bile acids, lipophilic, unconjugated bile
acids, such as ursodeoxycholic acids, are passively
reabsorbed. This provides the first essential step in the
cholehepatic shunt model (Hofmann et al., 1997), which
explains the phenomenon of bicarbonate rich hypercholeresis generated by these bile acids. The same phenomenon
was also demonstrated for weakly acidic drugs, such as the
anti-inflammatory sulindac (Hofmann et al., 1997). This
has lead to speculation that cholehepatic recycling of the
substances reabsorbed by BEC represents an additional
removal step for unconjugated substances from the bile.
As a major function of the liver is metabolism and
conjugation of xenobiotics and drugs to be then secreted
mainly as water-soluble metabolites into bile, substances
that escape hepatic conjugation/metabolism might be
excreted as hydrophobic (toxic) substances. However
passive reabsorption by BEC and the continuous recycling
likely are designed to ensure further conjugation/metabolism of these toxic metabolites. Final biliary excretion
appears to occur only when this class of substances is
rendered hydrophilic and non-toxic. In parallel, bile acids
are also efficiently recycled under normal conditions
after their release. Unconjugated, and to a lesser extent
also conjugated, bile acids are absorbed by passive
diffusion throughout the entire gut. However, an
active transport mechanism for conjugated bile acids
exists in the distal ileum. The reabsorbed bile acids
enter the portal circulation and are taken up rapidly
by hepatocytes, metabolized, and resecreted into the bile
(enterohepatic circulation). Normally, the bile acid pool
circulates approximately 5 –10 times daily and intestinal
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reabsorption is 95% efficient, so fecal loss of bile acids is
minimal. This loss is compensated by an equal daily
synthesis of bile acids by the liver, thereby the size of the
bile acid pool remains unchanged.
L -glutamate is released within the biliary tree from
glutathione via the action of g-glutamyl transferase
(GGT). It has been shown that BEC possess the capacity
for a sodium-dependent and sodium-independent
transport system for L -glutamate. These transport
systems are different from the hepatocellular system
since the inhibition and kinetic properties are different
(Eisenmann-Tappe et al., 1991). However, the localization
of these transporters has not been identified yet, and
therefore the physiological role of such a transport system
remains unclear.

IGA SECRETION
IgA is the major protein in bile and is the major and
characteristic immunoglobulin of the mucosal immune
system (Lemaitre-Coelho et al., 1977). Two different
pathways of IgA transport into bile are present. In humans,
the IgA is synthesized locally in plasma cells along the
biliary tree, bound to polymerized immunoglobulin
receptor (pIgR) on the basolateral membrane of BEC,
and transported, and secreted into the bile by BEC. In rats,
the IgA is cleared from plasma by pIgR located on the
sinusoidal surface of hepatocytes and delivered into bile.
The major pathway for IgA transport into bile is via a
receptor-binding interaction (Fig. 2). Studies in rats have
demonstrated that IgA is transported by pIgR, an
extracellular receptor present in the sinusoidal membrane
of hepatocytes. pIgR is synthesized as a transmembrane
glycoprotein and is expressed in a polar fashion on the
basolateral (or sinusoidal) surface of the cell, where it is
available to bind IgA. pIgR is synthesized by the epithelial
cells of all external-secreting organs (intestine, mammary
gland, lung, lacrimal gland, endometrium, etc.) as well as
by the hepatocytes and BEC (Takahashi et al., 1982;
Delacroix et al., 1984; Daniels and Schmucker, 1987), as
summarized in Table I.
IgA itself is synthesized in IgA-specific plasma cells as
heavy chains (alpha) and light chains (kappa or lambda)
which are assembled into monomeric IgA molecules (two
heavy chains and two light chains). In the presence of the J
chain addition peptide, monomeric units join via disulfide
linkages to create dimers and other multimeric forms of
IgA, which are then secreted. Only polymeric forms
of IgA have high affinity for and thus can bind to pIgR.
A tyrosine residue in the IgA molecule plays an important
role in the binding of IgA to pIgR, since binding and
transcytosis of IgA often are decreased after iodination of
the IgA (Schiff et al., 1986). The J chain is required
for the binding of IgA to pIgR and subsequent intracellular transport of IgA (Brandtzaeg and Prydz, 1984),
although pIgR does not interact directly with the J chain.
The first homologous domain at the NH2-terminal of pIgR
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FIGURE 2 Schematic representation of the transcellular pathway for
IgA secretion. Dimeric IgA secreted by plasma cells binds to pIgR, which
is located on the basolateral membrane of BEC. The IgA–pIgR complex
is internalized and transported across BEC is the vesicle. Upon arriving
the apical pole of BEC, pIgR is proteolytically processed, which releases
IgA coupled with secretory piece.

is necessary for binding IgA (Hanly et al., 1987) and at the
BEC surface, IgA first interact with pIgR noncovalently
(Lindh and Bjork, 1976). Later, the free sulfhydryl group
on the IgA molecule initiates the so-called disulfide
interchange reaction by reducing a disulfide bond on the
pIgR. This reaction leads ultimately to the formation of
two new inter-molecular disulfide bonds between the IgA
molecule and pIgR (Pardo et al., 1979). Interestingly,
even though some degree of cross-affinity between IgA
and pIgR of different species exists, the ability of IgA from
one species to bond covalently to pIgR of different species
is quite variable suggesting that the reaction requires
certain conformational characteristics of both the IgA and
the pIgR (Socken and Underdown, 1978).
TABLE I Predominant cellular location of pIgR in hepatobiliary tissues
in various animal species
Species
Rat
Rabbit
Mouse
Human
Monkey
Guinea pig

Location of pIgR
Hepatocytes
Hepatocytes
Hepatocytes
BEC
Unknown (not on hepatocytes)
BEC

After binding, the IgA –pIgR complexes are internalized into coated endocytic vesicles which are routed
across the epithelial cells (transcytosis) to the apical
pole. Transport of the formed complexes is size dependent
as pentameric IgM and large IgA immune complexes
are generally transported less efficiently into bile than
dimeric IgA (Socken et al., 1981). For example,
complexes of trinitrophenylated bovine thyroglobulin
(molecular weight of approximately 970 kDa) and
polymeric IgA were transported less well than IgAtrinitrophenylated human albumin complexes (molecular
weight of approximately 460 kDa). Soon after endocytosis, the IgA – pIgR complexes are localized in a
vesicular – tubular network, where the sorting of IgA–
pIgR complexes from other endocytosed ligands presumably occurs. The vesicles containing IgA – pIgR
complexes, smooth-coated and vary in size from 100 to
160 nm in diameter, then are transported across the cell,
avoiding interaction with lysosomes and Golgi complexes,
and fuse with the bile canalicular membrane (Hoppe et al.,
1985). This process also depends on functioning
microtubules since treatment with colchicine abolishes
the transport of IgA (Mullock et al., 1980) The
transcellular migration also appears to involve only
discrete vesicles, as there was no extensive connection
between structures in the sinusoidal and bile canalicular
regions (Hoppe et al., 1985).
The final step of the IgA delivery pathway involves the
proteolytic cleavage of the IgA – pIgR complexes at the
bile canalicular pole of the hepatocytes (or apical pole of
the BEC). At this step, pIgR is proteolytically processed to
yield two proteins: a soluble fragment of pIgR called
secretory piece (SC) and a transmembrane anchoring
fragment containing the cytoplasmic tail of pIgR, which
remains on the vesicular membrane. The SC is released
into the bile alone with IgA, where it acts to protect the IgA
from degradation thereby increasing the half-life of IgA in
the bile. The exact mechanism and location of this
proteolytic cleavage remain incompletely understood.
Immunohistochemical studies have shown an accumulation of IgA and pIgR at or near the bile canalicular
membrane before exocytosis of IgA (Takahashi et al.,
1982), suggesting that the fusion of the endocytic vesicle
with the bile canalicular membrane or the proteolysis of
pIgR is the rate-limiting step in the pathway. By using the
monoclonal antibodies specific for the cytoplasmic tail of
pIgR, it has been shown that either the cytoplasmic tail
itself or other slightly degraded fragments are also released
into the bile, as opposed to being degraded intracellularly
(Solari et al., 1986). Interestingly, the SC is proteolytically
processed for a second time by a metalloprotease present
on the brush border plasma membrane of the jejunum into
a smaller form (Ahnen et al., 1986).
The role and, therefore, the biological significance of the
transport of IgA from the plasma into the bile have not been
clearly defined. However, there are at least three proposed
functions (Fig. 3). First, IgA in bile provides protection for
the biliary tree and liver against invading pathogens by
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FIGURE 3 Proposed function of antibody in the bile. (1) Binding to
extracellular pathogen and preventing its attachment to the BEC. (2)
Binding to free antigen, forming immune complex, and facilitating its
excretion. (3) Binding to intracellular pathogen during its transcytosis.

preventing the attachment of microorganisms and/or their
toxins. Natural IgA antibodies to various intestinal bacteria
are present in bile and inoculation into the intestinal lumen
or intestinal lymphoid tissues of various antigens resulted
in specific IgA antibodies in bile and protected experimental animals from, for example, cholangitis (Aagaard et al.,
1996). Second, potential harmful antigens present in the
circulation can be cleared into bile in the form of immune
complexes with IgA, thereby reducing the possibility of a
systemic reaction. Indeed, transport of intravenously
injected free antigen into bile by circulating IgA, either
passively administered or actively induced, has been
demonstrated in rats. This could be especially important
since a state of chronic inflammation might constantly arise
given that the gastrointestinal tract is in contact with
enormous diversity and amount of antigens daily (Harmatz
et al., 1982; Peppard et al., 1982). A third possible role for
the transport of IgA from plasma into bile is to provide
specific protection against invading microorganisms as
during the transcytosis process, the IgA antibodies can
encounter and bind to an intracellular microbial pathogen.
For example, co-localization of viral envelope proteins of
Sendai and influenza viruses and IgA monoclonal
antibodies specific to that viral protein has been
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demonstrated by 2-color immunofluorescence in a recent
study (Mazanec et al., 1995).
Different animal species have different capacities to
transfer IgA from plasma into bile as well as different
location of pIgR within the liver. Other factors may
also influence the IgA transport and pIgR expression.
For example, the synthesis and expression of pIgR appears
to be regulated during cellular differentiation and
development. In the rat, immunorecognizable pIgR appears
in intestinal epithelial cells between 10 and 15 days after
birth, corresponding to the appearance in the lamina
propria of IgA-producing plasma cells (Nagura et al.,
1978). pIgR then reaches adult levels of expression by 40
days after birth. In rats, the hepatobiliary secretion of IgA
decreases with age, as a direct result of an age-related
decrease in the number of pIgR present on hepatocytes
(Daniels et al., 1985). In contrast, in humans, pIgR has a
different time course and is observed in fetal tissues prior to
the appearance of either IgA or IgA-producing plasma cells
(Ogra et al., 1972).
The regulation of the expression of pIgR, and
consequently the transport of IgA into external secretions
may be tissue-specific as well as dependent on specific
hormones and other chemical influences. The amount of
pIgR synthesized by uterine or lacrimal cells may be
influenced by sex steroids (Sullivan and Wira, 1981;
Sullivan et al., 1984) as pIgR concentration in the tears of
male rats is approximately 5-fold greater than that in a
female. Castration results in a decrease of pIgR
concentration in the tears. In hepatocytes, regulation of
pIgR synthesis by glucocorticoids was also noted (Wira
and Colby, 1985) as pIgR increased significantly after the
addition of cortisol to the culture medium. Furthermore,
this effect was abolished when either estradiol or
cyclohexamide was added to the medium, which indicates
that expression of pIgR is controlled both transcriptionally
and translationally. Additionally, the synthesis and
secretion of pIgR by HT-29 cells, a human colonic
carcinoma cell line, can be increased by treatment with
g-interferon (g-IFN) (Sollid et al., 1987), tumor necrosis
factor (TNF)-a (Kvale et al., 1988), or by growing the
cells in glucose-free, galactose-substituted medium (Rao
et al., 1987).
The transport of IgA into bile is related to bile flow.
Transient bile duct ligation (2 h) dramatically decreased
liver transport of IgA in the period subsequent to ligation
(Kloppel et al., 1987). The amount of IgA secreted into the
bile was decreased to one-tenth of control value before
ligation. In the rat, treatment with 17a-ethnylestradiol
(5 mg/kg for 5 days) reduced bile flow by greater than
60%. In parallel, the transport of intact IgA into bile
decreased by 43% (Goldsmith et al., 1987). Table II
summarizes the regulation of pIgR expression and/or IgA
transport by various agents.
In addition to IgA, other subclasses of immunoglobulins
are also present in the bile. The concentration of biliary
IgG is less than 8% the concentration of serum IgG
(Manning et al., 1984). It appears that bile IgG mainly
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TABLE II Regulation of pIgR expression/IgA transport by various
agents
Effect on pIgR expression/IgA transport
Increase

Decrease

Androgen
Cortisol
IFN-g
TNF-a

Aging
Bile duct ligation
17a-ethnylestradiol

originates from diffusion from blood. However, this
mechanism was not supported in one study on human bile
after tetanus toxoid immunization. The kinetics of the
biliary IgG response in this study differed significantly
from that found in serum. Moreover, when compared with
paired sera response, the peak response in the bile
exceeded that of the sera and showed 19-fold more
abundant IgG and 45-fold more abundant IgA than could
have arrived by diffusion. This suggests that intrahepatic
antibody production for export to the intestinal tract may
occur in humans (Hansen et al., 1989). Similar to the
origins of IgG, trace amounts of IgM in bile may be either
the result of leakage from blood or the presence of local
IgM-producing plasma cells within the liver. The latter is
supported by another study which showed that antigen
entering the bloodstream stimulated a population of cells
in the spleen to migrate to the liver. These cells then
produce and secrete IgM into bile, thereby providing rapid
and localized immunological response to invading
microorganisms (Jackson and Walker, 1983).

IMMUNE RESPONSE ROLE-SYNTHESIS OF
CHEMOKINES, CYTOKINES, AND OTHER
MEDIATORS
The ability of BEC to express and secrete chemokines and
cytokines is crucial for biliary innate immune defenses
since these cells are the initial contact points for potential
pathogenic microorganisms in the bile or ascending from
the intestinal tract via the biliary tree. Locally secreted
chemokines and cytokines are important signals for
recruitment of other immune cells. Human BEC express
and secrete IL-8 and monocyte chemotactic protein-1
(MCP-1) promoting the recruitment of neutrophils and
monocytes or T-lymphocytes, respectively, to the portal
tracts. When stimulated with proinflammatory cytokines
such as interleukin (IL)-1 or TNF-a, this response is rapidly
upregulated. When BEC were cocultured in transwell
chamber below monolayers of endothelial cells, the
transendothelial migration of neutrophils was observed.
This response was blocked by antibodies to CD18 or CD11
but only partially inhibited by antibodies to IL-8 (Morland
et al., 1997). IFN-g had a differential effect since it
reduced IL-8 but enhances MCP-1 secretion. The recruited
neutrophils, monocytes, or T-lymphocytes can act as part of
a protective response against ascending biliary infections

or as participants in the pathological inflammation of the
bile ducts like in PBC.
Studies of BEC in culture have shown that IL-6
synthesis and secretion into the medium. The TNF
receptor and to a lesser extent IL-6 receptor a chain are
also present in BEC. Damaged BEC also have an
increased expression of both IL-6 mRNA and TNF-a
mRNA compared to normal liver suggesting an possible
autocrine effect (Yasoshima et al., 1998). The secreted
IL-6 and TNF-a could act in a paracrine or autocrine
fashion as IL-6 increases BEC DNA labeling index from
4- to 6-fold after 24 h in primary cultures maintained in
serum-free conditions and promotes BEC proliferation
in vitro (Matsumoto et al., 1994). Second, these cytokines
have an effect on lymphocytes in the vicinity of portal
tracts. For example, IL-6 may promote terminal
differentiation of B cells and stimulate secretion of
immunoglobulins. TNF-a may induce expression of
various adhesion molecules on BEC (Ayres et al., 1993)
as well as the cytotoxic activities of T lymphocytes.
Finally, IL-6 and TNF-a may mediate direct tissue
damage by means of inflammation and apoptosis as
treatment with TNF-a induced apoptosis in cultured rat
hepatocytes (Bour et al., 1996).
BEC also synthesize and secrete other peptides and
mediators, such as transforming growth factor (TGF)-b2
(Milani et al., 1991), endothelin-1 (Caligiuri et al., 1998),
platelet-derived growth factor (PDGF)-B chain (Milani
et al., 1991), and nitric oxide (NO) (Vos et al., 1997). BEC
do not produce these mediators under normal physiological conditions, but actively synthesize them in many
conditions of acute and chronic liver injury. Thus,
activated BEC communicate extensively with other
immunological cells, including lymphocytes, neutrophils,
fibroblasts, and Kupffer cells (macrophages).

IMMUNE RESPONSE ROLE-EXPRESSION OF
ADHESION MOLECULES
BEC could intensify and localize the immune response by
expressing selected cell surface adhesion molecules. Both
in vivo and in vitro BEC from both diseased and normal
livers express intercellular adhesion molecules (ICAM)-1,
leukocyte function antigen (LFA) -3, major histocompatibility complexes (MHC)-I, and to a lesser degree, MHC-II
constitutively in primary cultures (Ayres et al., 1993;
Cruickshank et al., 1998) (Fig. 4). When treated with
proinflammatory cytokines such as TNF-a, IFN-g, or IL-1,
a significant increase of ICAM-1, MHC-I, and MHC-II
expression was noted from both the diseased and normal
liver (Ayres et al., 1993). In another study using BEC
cell lines (PLC/PRF/5, HepG2, Hep3B, and CC-SW),
all expressed MHC-I, LFA-3, ICAM-1, and EGF receptor.
Furthermore, all but Hep3B expressed CD95. Similarly,
proinflammatory cytokines such as IFN-g and TNF-a
upregulated surface expression of ICAM-1, MHC-1, and
MHC-II. IL-4, a Th2 cytokine, also upregulated CD95
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FIGURE 4 BEC constitutively express certain adhesion molecules, including ICAM-1, LFA-3, and CD40, which interact with surrounding
lymphocytes expression LFA-1, CD2, and CD40L. BEC also express MHC-I and MHC-II, making them cytotoxic targets and/or becoming professional
APC. Cytokines produced by BEC have either autocrine or paracrine effects, which can modulate the functions of other immunological cells in the
vicinity.

expression while TGF-b, an anti-inflammatory cytokine,
markedly downregulated cell surface expression of CD95,
but increased expression of LFA-3 (Cruickshank et al.,
1998). The effect of proinflammatory cytokines on the
expression of adhesion molecules and MHC-I is consistent
with the hypothesis that BEC are not innocent bystanders
during inflammatory responses but active participants in
the inflammatory reactions observed in liver immunemediated disorders (Table III).
As BEC express MHC-I and LFA-3, important adhesion
molecules for lymphocyte trafficking and recognition, they
can also act as targets for cytolytic T cells. It has been
demonstrated that allogeneic lymphocytes could bind to
human primary BEC cultures and this interaction was
enhanced by activation of either participating cell types.
At least 50% of the overall interaction is dependent on
LFA-1 on cytotoxic T-lymphocytes, which is the ligand for
ICAM-1 expressed on BEC. BEC are also susceptible to
lysis by cytokine-activated natural killer (NK) cells
(Leon et al., 1997). In the presence of antigen in association
with MHC molecules, the lymphocytes would become
activated to recognize BEC as a potential target and
TABLE III Effect of cytokines on the expression of membrane surface
markers in BEC
ICAM-1 MHC-I MHC-II
Unstimulated
TNF-a
IFN-g
IL-1
TGF-b
IL-4
NA, not available.

þ
"
"
"
#
NA

þ
"
"
"
#
NA

^
"
"
"
#
NA

LFA-3

CD95

CD40

þ
No effect
No effect
NA
"
NA

þ
NA
NA
NA
#
"

þ
"
"
NA
No effect
NA

expression of adhesion molecules would then render them
susceptible to cytolytic mechanisms by attracting cytotoxic
T lymphocytes (CTL). It is also possible that upregulated
expression of MHC-I on BEC increases the avidity of the
T cell receptor (TCR)/MHC interaction, which in turn
increases their potential as target cells for T cell-mediated
attack. The fact that LFA-3 is constitutively expressed on
BEC suggests an interaction with CD2 on CTL and/or NK
cells that may lead to cytotoxicity (Leon et al., 1997). It has
also been found that TCR stimulation or treatment with
phorbol ester rapidly increased the avidity of CD2 for LFA3 in murine T cell hybridomas transfected with human CD2
(Hahn et al., 1993). Cell lines expressing single amino acid
mutations of the carboxyl terminal asparagines of CD2 lost
CD2 avidity regulation through TCR activation. This
regulation requires both protein tyrosine kinases and
protein kinase C. Agents that increase intracellular cAMP
levels also upregulated CD2 avidity. In conclusion, the
CD2/LFA-3 interaction not only acts as the physical bridge
between T lymphocytes and BEC but also are affected by or
turn on other signal transduction pathways
Viral infection can also modulate BEC expression of
adhesion molecules. For example, cytomegalovirus
(CMV) infection increased BEC surface expression of
MHC-I but not MHC-II (Scholz et al., 1997). This
augmentation of MHC-I expression was observed when
the virally infected BEC was cocultured with autologous
but not allogeneic peripheral blood lymphocytes. CMV
also reduced the IFN-g mediated induction of MHC-II
while MHC-I was unchanged. This also suggests that a
viral infection can modulate the immunogenic potential of
BEC by making them more susceptible to T lymphocyte
attack due to increased MHC-I expression.
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An earlier study has confirmed the constitutive
expression of MHC-II from primary BEC cultures of
both normal and diseased livers (Cruickshank et al., 1998)
and that proinflammatory cytokines such as TNF-a, IFNg, or IL-1 upregulated the MHC-II expression of BEC.
The reason for this expression of MHC-II on BEC remains
unclear although this has lead to suggestions that BEC
might act as professional antigen presenting cells (APC)
as APC are characterized by MHC-II expression.
For example, it has been shown that the increased
destruction of bile duct epithelium is associated with
MHC-II-specific lymphocytes. In vivo studies have also
shown that intraperitoneal administration of IL-2 in mice
induces not only luminal expression of MHC-II on BEC,
but also lymphocyte infiltration around bile ducts in liver
(Himeno et al., 1992). Most infiltrating lymphocytes were
T cells and about one-third of them were positive for IFNg suggesting that the infiltration of lymphocytes is
dependent on endogenous IFN-g production. However it
is well accepted that the expression of MHC-II alone is not
sufficient for antigen presentation to naı̈ve T lymphocytes
as successful primary activation and subsequent proliferation of T cells by APC requires costimulatory signals,
B7-1 (CD80) and B7-2 (CD86). However, neither CD80
nor CD86 are constitutively expressed by unstimulated
human BEC and high concentrations of either IFN-g,
TNF-a, or both in combination failed to induce their
expression on BEC (Leon et al., 1997). While this argues
that BEC are unlikely to act as professional APC, it is still
possible that BEC may present antigens in an inefficient
manner which may result in specific T cell anergy or
deletion. The anergic T cells may function as suppressor
cells, inhibiting subsequent T cell activation even in the
presence of professional APC.
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